Signal Transduction Interception as a Novel Approach to Disease Management

This publication has 14 references indexed in Scilit:

• Tyrosine Kinase Inhibition: An Approach to Drug Development
  Science, 1995
• Signal-Transduction Therapy. A Novel Approach to Disease Management
  European Journal of Biochemistry, 1994
• Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors
  Science, 1994
• 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.
  Proceedings of the National Academy of Sciences, 1994
• Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate
  Blood, 1993
• Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.
  Molecular and Cellular Biology, 1993
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells
  American Journal of Physiology-Cell Physiology, 1991
• A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization.
  Molecular and Cellular Biology, 1991
• Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors
  Science, 1988